The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis

BACKGROUND: To compare the efficacy of three types of palliative therapy for advanced hepatocellular carcinoma (HCC), including transarterial chemoembolisation (TACE) monotherapy, sorafenib alone and their combination. METHODS: The databases of PubMed, Embase and Cochrane Library were retrieved. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Zhoujing, He, Lin, Guo, Yingjie, Song, Yuhua, Song, Shasha, Zhang, Lijiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488414/
https://www.ncbi.nlm.nih.gov/pubmed/32917226
http://dx.doi.org/10.1186/s12957-020-02017-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488414/
https://www.ncbi.nlm.nih.gov/pubmed/32917226
http://dx.doi.org/10.1186/s12957-020-02017-0

Ejemplares similares